Open AccessColistin Therapy, Survival and Renal Replacement Therapy in Burn Patients: A 10-Year Single-Center Cohort Study
Author(s) -
Filippo Mariano,
Valeria Malvasio,
Daniela Risso,
Nadia Depetris,
Anna Pensa,
Giacomo Fucale,
Fabrizio Gennari,
Luigi Biancone,
Maurizio Stella
Publication year - 2022
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s357427
Subject(s) - colistin , medicine , renal replacement therapy , acinetobacter baumannii , antibiotics , cohort , acute kidney injury , retrospective cohort study , pseudomonas aeruginosa , surgery , microbiology and biotechnology , genetics , bacteria , biology
Colistin is still a therapeutic cornerstone against multidrug-resistant gram-negative bacteria (MDRGN), mostly when other antibiotics do not gain adequate activity on these strains. In the present study, we evaluated in a cohort of burn patients the relationship between colistin therapy, survival and requirement of renal replacement therapy (CRRT).